Affiliated with a Castle Connolly Top Hospital
Who is Dr. Fathman, Allergist & Immunologist in Stanford, CA?
Dr. C. Garrison Fathman, MD is an Allergist & Immunologist, who primarily practices in Stanford, CA with 1 additional practice location. Dr. Fathman is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Fathman’s office at (650) 723-7887.
What are Areas of Expertise for Dr. Fathman?
Dr. C. Garrison Fathman, MD is a highly-rated, board-certified Allergist & Immunologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Fathman empowers patients to confidently navigate their health journey, specializing in Immune Deficiency, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Fathman is dedicated to enhancing lives through expert, patient-centered care.
What languages does Dr. Fathman speak?
Dr. Fathman and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does an Allergist & Immunologist like Dr. Fathman typically treat?
As an Allergist & Immunologist, conditions treated by Dr. C. Garrison Fathman may include:
Please contact Dr. Fathman's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does an Allergist & Immunologist like Dr. Fathman typically perform?
As an Allergist & Immunologist, procedures performed by Dr. C. Garrison Fathman may include:
- Allergy Consultation
- Allergy Follow Up
- Allergy Shots
- Allergy Testing
- Insect Bite(s)
- Sinus Surgeon Consultation
- Sinus Surgeon Follow Up
- Sinus Surgery
Please contact Dr. Fathman's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Fathman accept my insurance?
Please contact Dr. Fathman's office to confirm accepted insurance plans.
Where is Dr. Fathman's office located?
What hospitals are Dr. Fathman affiliated with?
Castle Connolly Top Hospital
This doctor is affiliated with a Castle Connolly Top Hospital.
Dr. Fathman has admitting privileges at the following hospitals:
Recognitions
Publications
Reduced DEAF1 function during type 1 diabetes inhibits translation
, 2013
New tools for classification and monitoring of autoimmune diseases
, 2012
Exploiting a tural conformatiol switch to engineer an interleukin-2 'superkine'
, 2012
Therapeutic Effects of Systemic Administration of Chaperone alpha B
, 2012
Differential mTOR and ERK pathway utilization by effector CD4 T cells suggests combitorial drug
, 2012
GRAIL: a unique mediator of CD4 T-lymphocyte unresponsiveness
, 2011
A Short Pulse of IL-4 Delivered by DCs Electroporated With Modified mR Can Both Prevent
, 2010
A model for harmonizing flow cytometry in clinical trials.
, 2010
New technologies for autoimmune disease monitoring
, 2010
Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens
, 2009
The Transmembrane E3 Ligase GRAIL Ubiquitites and Degrades CD83 on CD4 T Cells
, 2009
Lymphoid tissue-specific homing of bone marrow-derived dendritic cells
, 2009
ive CD4 T Cell Proliferation Is Controlled by Mammalian Target of Rapaiycin Regulation of GRAIL
, 2009
Tissue- and age-specific changes in gene expression during disease induction and progression in NOD
, 2008
The single subunit transmembrane E3 ligase gene related to anergy in lymphocytes
, 2008
Cutting edge: The transmembrane E3 ligase GRAIL ubiquitites the costimulatory molecule CD40 ligand
, 2008
Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL
, 2008
ive and memory T cells induce different types of graft-versus-host disease
, 2007
Multimodality imaging of T-cell hybridoma trafficking in collagen-induced arthritic mice
, 2007
Molecular mechanisms of CD4(+) T-cell anergy
, 2007
A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a
, 2006
Does our current underst
, 2006
T cell anergy: Where it's LAT
, 2006
CYLD: deubiquitition-induced TCR sigling
, 2006
Developing the concept of adoptive cellular gene therapy of rheumatoid arthritis
, 2006
CD4(+)CD25(+) regulatory T cells and their therapeutic potential
, 2006
L-selectin and beta(7) integrin on donor CD4 T cells are required for the early migration to host
, 2005
Targeted gene therapy of autoimmune diseases: advances and prospects.
, 2005
Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection
, 2005
An array of possibilities for the study of autoimmunity
, 2005
Only the CD62L(+) subpopulation of CD4(+)CD25(+) regulatory T cells protects from lethal acute GVHD
, 2005
Protein microarrays for multiplex alysis of sigl transduction pathways
, 2005
Fostering interdiscipliry immunology
, 2005
Protein microarrays for multiplex alysis of sigl transduction pathways
, 2004
Murine CD4(+) CD25(+) regulatory T cells fail to undergo chromatin remodeling across the proximal
, 2004
Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunity
, 2004
The gene related to anergy in lymphocytes, an E3 ubiquitin ligase
, 2004
Targeted gene therapy: frontiers in the development of 'smart drugs'
, 2004
Two isoforms of otubain 1 regulate T cell anergy via GRAIL
, 2004
Costimulatory sigls controlling regulatory T cells
, 2003
CD4(+)CD25(+) regulatory T cells preserve graft-versus
, 2003
Localized expression of an anti-TNF single
, 2003
GRAIL: An E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic
, 2003
Treatment of autoimmune disease by adoptive cellular gene therapy
, 2003
Scratching the (T cell) surface.
, 2003
T-cell anergy - From phenotype to genotype and back
, 2003
Short polymers of arginine rapidly translocate into vascular cells
, 2002
Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4
, 2002
CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity
, 2002
The potential for gene therapy in the treatment of autoimmune disease
, 2002
The Subpopulation of CD4(+) CD25(+) splenocytes that delays adoptive transfer
, 2002
Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft
, 2002
Adoptive cellular gene therapy of autoimmune disease.
, 2002
Immunomodulatory vaccition in autoimmune disease
, 2002
A complicated relationship
, 2002
Bioluminescence imaging of lymphocyte trafficking in vivo
, 2001
Gene therapy in autoimmune disease
, 2001
CD4(+)CD25(+) T cells facilitate the induction of T cell anergy
, 2001
Autoimmune diseases: genes, bugs and failed regulation
, 2001
Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL
, 2001
Immunization with D encoding an immunodomint peptide of insulin prevents diabetes in NOD mice
, 2001
Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis
, 2001
T cell receptor (TCR)
, 2000
Rapid and efficient vascular transport of arginine polymers inhibits myointimal hyperplasia
, 2000
Polyarginine enters cells more efficiently than other polycationic homopolymers
, 2000
Targeting rare populations of murine antigen
, 2000
Gene therapy for autoimmune disease
, 2000
Identification and characterization of the antigen
, 2000
Application of gene therapy in autoimmune disease.
, 2000
The application of gene therapy in autoimmune diseases
, 2000
Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4
, 1999
A new look at MHC and autoimmune disease.
, 1999
Suppressive immunization with D encoding a self-peptide prevents autoimmune disease
, 1999
Local delivery of TNF by retrovirus
, 1999
Alysis of the role of variation of major histocompatibility complex cl
, 1998
T cell receptor (TCR) engagement leads to activation
, 1998
Following antigen challenge
, 1998
Prolongation of cardiac graft survival with anti-CD4Ig plus hCTLA4Ig in primates
, 1998
Regulation of programmed cell death following T cell activation in vivo
, 1998
A gene therapy approach to treatment of autoimmune disease
, 1998
The association of MHC with autoimmune diseases
, 1998
CD45RB(high) CD4(+) T cells from IFN-gamma knockout mice do not induce wasting disease
, 1997
Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide
, 1997
Rat pancreatic islet and skin xenograft survival in CD4 and CD8 knockout mice
, 1997
Local delivery of interleukin 4 by retrovirus
, 1997
The use of CD4 and CD8 knockout mice to study the role of T
, 1997
Induction of tolerance to small bowel allografts in high-responder rats by combining anti
, 1996
CD4(+) but not CD8(+) cells are essential for allorejection
, 1996
beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice
, 1996
Quantitative alysis of T cell activation - Role of TCR ligand density and TCR affinity
, 1996
Breaking self-tolerance in nonobese diabetic mice
, 1996
Immune regulation in type 1 diabetes
, 1996
Monoclol T cells identified in early NOD islet infiltrates
, 1996
Treatment of experimental encephalomyelitis with a peptide alogue of myelin basic protein
, 1996
Pathogenic and protective roles of CD45RB(low) CD4(+) cells correlate with cytokine profiles in the
, 1996
Mice with a disrupted IFN
, 1996
Tissue-specific effects of anti-CD4 therapy in induction of allograft unresponsiveness in high
, 1995
TERRY COMPLEX THERAPY FOR AUTOIMMUNE-DISEASE
, 1995
INDUCTION OF TOLERANCE TO HEART ALLOGRAFTS IN HIGH RESPONDER RATS BY COMBINING ANTI
, 1995
CD4-POSITIVE SUPPRESSOR CELLS BLOCK ALLOTRANSPLANT REJECTION
, 1995
ISLET-INFILTRATING LYMPHOCYTES FROM PREDIABETIC NOD MICE RAPIDLY TRANSFER DIABETES TO NOD-SCID
, 1995
REGULATION OF AUTOIMMUNE-RESPONSE
, 1994
PREVENTION OF DIABETES AND INSULITIS BY NEOTAL INTRATHYMIC ISLET ADMINISTRATION IN NOD MICE
, 1994
CD4-POSITIVE HEAT-STABLE ANTIGEN-POSITIVE THYMOCYTES CAUSE GRAFT-VERSUS-HOST DISEASE ACROSS
, 1994
IMMUNOTHERAPEUTIC STRATEGIES DIRECTED AT THE TRIMOLECULAR COMPLEX
, 1994
MECHANISMS OF TRANSPLANTATION TOLERANCE
, 1994
SELECTION FOR AMINO-ACID-SEQUENCE AND J-BETA-ELEMENT USAGE IN THE BETA-CHAIN OF DBA 2V BETA
, 1993
PEPTIDES AS THERAPY OF AUTOIMMUNE-DISEASE
, 1993
INDUCTION OF RELAPSING PARALYSIS IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY BACTERIAL
, 1993
EVIDENCE THAT CLOL ANERGY IS INDUCED IN THYMIC MIGRANT CELLS AFTER ANTI-CD4
, 1993
SEB INDUCED ANERGY - MODULATION OF IMMUNE
, 1993
THE USE OF GRANZYME A AS A MARKER OF HEART-TRANSPLANT REJECTION IN CYCLOSPORINE OR ANTI
, 1993
REQUIREMENT FOR CD8+ CELLS IN T-CELL RECEPTOR PEPTIDE-INDUCED CLOL UNRESPONSIVENESS
, 1993
EVIDENCE THAT ANTI-CD8 ABROGATES ANTI
, 1993
Anti-CD4 antibodies in diabetes.
, 1993
AMELIORATION OF AUTOIMMUNE ENCEPHALOMYELITIS BY MYELIN BASIC
, 1992
IMMUNOTHERAPY OF RHEUMATIC DISEASES BASED ON UNDERSTANDING GENETIC PREDISPOSITION TO THE
, 1992
ANTI-CD4 MONOCLOL-ANTIBODIES IN THERAPY - CREATION OF NONCLASSICAL TOLERANCE IN THE ADULT
, 1992
LIMITED T-CELL RECEPTOR BETA-CHAIN USAGE IN THE SPERM WHALE MYOGLOBIN 110-121
, 1992
What a rheumatologist needs to know about T cell receptor structure and function.
, 1992
PRESENTATION OF ANTIGEN BY MIXED ISOTYPE CLASS-II MOLECULES IN NORMAL H-2D MICE
, 1992
ANTI-CD8 ABROGATES EFFECT OF ANTI-CD4-MEDIATED ISLET ALLOGRAFT SURVIVAL IN RAT MODEL
, 1991
GENETIC DISSECTION OF T-CELL RECEPTOR-V-BETA GENE REQUIREMENTS FOR SPONTANEOUS MURINE DIABETES
, 1991
THE T-CELL RECEPTOR REPERTOIRE INFLUENCES V-BETA ELEMENT USAGE IN RESPONSE TO MYOGLOBIN
, 1991
ALYSIS OF THE TERRY COMPLEX OF ANTIGEN
, 1991
MOLECULAR ALYSIS OF THE ROLE OF THE HLA CLASS-II GENES DRB1, DQA1
, 1991
ANTI-CD4 MEDIATES CLOL ANERGY DURING TRANSPLANTATION TOLERANCE INDUCTION
, 1991
GENETIC-ALYSIS OF DIABETES IN THE NONOBESE DIABETIC MOUSE .1. MHC AND T
, 1991
DRB1-STAR-LY10 - A NEW DRB1 ALLELE AND ITS HAPLOTYPIC ASSOCIATION
, 1990
T-CELL RECEPTOR-MEDIATED NEGATIVE SELECTION OF AUTOREACTIVE LYMPHOCYTE-T PRECURSORS OCCURS AFTER
, 1990
INDUCTION OF DONOR-SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS BY PRETRANSPLANT ANTI
, 1990
THE PRESUMPTIVE CDR3 REGIONS OF BOTH T-CELL RECEPTOR ALPHA
, 1990
SHARED MOLECULAR MARKERS OF GENETIC PREDISPOSITION TO SEROPOSITIVE RHEUMATOID-ARTHRITIS
, 1990
CARDIAC ALLOGRAFT PROLONGATION IN MICE TREATED WITH COMBINED POSTTRANSPLANTATION TOTAL
, 1989
A SUBSET OF MEMORY CD4+ HELPER LYMPHOCYTES-T IDENTIFIED BY EXPRESSION OF PGP-1
, 1989
ENHANCED CELL-MEDIATED PROTECTION AGAINST FATAL ESCHERICHIA
, 1989
A NEW LOOK AT THE SHARED EPITOPE HYPOTHESIS
, 1988
USE OF ANTI-L3T4 AND ANTI-IA TREATMENTS FOR PROLONGATION OF XENOGENEIC ISLET TRANSPLANTS
, 1988
IMMUNOTHERAPY OF THE NONOBESE DIABETIC MOUSE - TREATMENT WITH AN ANTIBODY TO T-HELPER LYMPHOCYTES
, 1988
ADMINISTRATION INVIVO OF RECOMBINT INTERLEUKIN-2 PROTECTS MICE AGAINST SEPTIC DEATH
, 1987
MODULATION OF CD4 BY ANTIGENIC ACTIVATION
, 1987
CLONING OF HUMAN ALLOREACTIVE T-CELLS
, 1987
LONG-TERM HUMORAL UNRESPONSIVENESS INVIVO, INDUCED BY TREATMENT WITH MONOCLOL-ANTIBODY AGAINST L3T4
, 1986
GENE CONVERSION - A MECHANISM TO EXPLAIN HLA-D REGION AND DISEASE ASSOCIATION
, 1986
SHARED T-CELL RECOGNITION SITES ON HUMAN HISTOCOMPATIBILITY LEUKOCYTE ANTIGEN CLASS
, 1986
HUMAN T-CELL CLONES USED TO DEFINE FUNCTIOL EPITOPES ON HLA CLASS-II MOLECULES
, 1986
HUMAN T-CELL CLONES AS DIAGNOSTIC-TOOLS AND POTENTIAL THERAPEUTIC REAGENTS
What is Dr. Fathman's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Fathman's National Provider Identifier (NPI) number is 1770619926.
What common questions do patients ask about Dr. Fathman?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Fathman
What is Dr. C. Garrison Fathman's specialty?
Dr. Fathman is an Allergist & Immunologist near Stanford, CA.
What does an Allergist & Immunologist do?
An allergist-immunologist is well-versed in the assessment, physical examination, laboratory diagnosis, and treatment of immune system disorders. These conditions include, but are not limited to, eczema, asthma, anaphylaxis, rhinitis, and adverse reactions to food, medication, and insect stings. Furthermore, they manage immune deficiency diseases, whether acquired or congenital, issues with host defense, and challenges associated with autoimmune diseases, organ transplantation, or immune system malignancies.
Is Dr. C. Garrison Fathman affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Fathman is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see an Allergist & Immunologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see an Allergist & Immunologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Dr. C. Garrison Fathman accepting new patients in Stanford, CA?
Yes, Dr. C. Garrison Fathman is accepting new patients at this time.
Does Dr. C. Garrison Fathman offer online booking?
Please contact Dr. Fathman's office at (650) 723-7887 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Dr. C. Garrison Fathman?
Please contact Dr. Fathman's office at (650) 723-7887 to schedule an appointment.
Where is Dr. Fathman's office located?
Dr. Fathman's offices are located in Stanford, CA and Palo Alto, CA.
Other Allergist & Immunologist Near Stanford, CA
Allergist & Immunologist
Accepting patientsPediatrician
Accepting patients
Allergist & Immunologist
Accepting patients